aluates Reports

$ 0.0

Automative

Global Semi-Solid Dose Market Research Report 2026

Published Date: 2026-06-11

Report Code: QYRE-Auto-37E13733

Global Semi Solid Dose Market Research Report 2023

BUY CHAPTERS

Global Semi-Solid Dose Market Research Report 2026

Code: QYRE-Auto-37E13733

Report

2026-06-11

Pages:130

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Johnson & Johnson

Merck

Bayer

Glenmark Pharmaceuticals

Cipla Ltd

Nestle SA

Novartis

GlaxoSmithKline PLC

Bausch Health Companies

Hisamitsu Pharmaceutical

Johnson & Johnson

Semi-Solid Dose Market

The global Semi-Solid Dose market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Semi-Solid Dose competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

A type of medication that is neither solid nor liquid; they are somewhere in between the two states.

The North American market for Semi-Solid Dose is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Semi-Solid Dose is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

Major global manufacturers of Semi-Solid Dose include Johnson & Johnson, Merck & Co, Bayer AG, Hisamitsu Pharmaceutical, Glenmark Pharmaceuticals, Cipla Ltd, Nestle SA, Novartis AG, GlaxoSmithKline plc, Bausch Health Companies, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Semi-Solid Dose market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Semi-Solid Dose. The Semi-Solid Dose market size, estimates, and forecasts are provided in terms of output/shipments (Tons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Semi-Solid Dose market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Semi-Solid Dose manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Semi-Solid Dose Market Report

Report Metric	Details
Report Name	Semi-Solid Dose Market
Segment by Type	Ointments Pastes Gels
by Application	Skin Nasal Cavity Vaginal Cavity Rectal Cavity Others
Production by Region	North America Europe China Japan
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Johnson & Johnson, Merck & Co, Bayer AG, Hisamitsu Pharmaceutical, Glenmark Pharmaceuticals, Cipla Ltd, Nestle SA, Novartis AG, GlaxoSmithKline plc, Bausch Health Companies
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Semi-Solid Dose manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.
Chapter 3: Examines Semi-Solid Dose production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.
Chapter 4: Analyzes Semi-Solid Dose consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.
Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.
Chapter 8: Reviews the industry value chain, including upstream and downstream segments.
Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 10: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Semi-Solid Dose Market report?

Ans: The main players in the Semi-Solid Dose Market are Johnson & Johnson, Merck & Co, Bayer AG, Hisamitsu Pharmaceutical, Glenmark Pharmaceuticals, Cipla Ltd, Nestle SA, Novartis AG, GlaxoSmithKline plc, Bausch Health Companies

What are the Application segmentation covered in the Semi-Solid Dose Market report?

Ans: The Applications covered in the Semi-Solid Dose Market report are Skin, Nasal Cavity, Vaginal Cavity, Rectal Cavity, Others

What are the Type segmentation covered in the Semi-Solid Dose Market report?

Ans: The Types covered in the Semi-Solid Dose Market report are Ointments, Pastes, Gels

1 Semi-Solid Dose Market Overview

1.1 Product Definition

1.2 Semi-Solid Dose by Type

1.2.1 Global Semi-Solid Dose Market Value Growth Rate Analysis by Type: 2025 vs 2032

1.2.2 Ointments

1.2.3 Pastes

1.2.4 Gels

1.3 Semi-Solid Dose by Application

1.3.1 Global Semi-Solid Dose Market Value Growth Rate Analysis by Application: 2025 vs 2032

1.3.2 Skin

1.3.3 Nasal Cavity

1.3.4 Vaginal Cavity

1.3.5 Rectal Cavity

1.3.6 Others

1.4 Global Market Growth Prospects

1.4.1 Global Semi-Solid Dose Production Value Estimates and Forecasts (2021–2032)

1.4.2 Global Semi-Solid Dose Production Capacity Estimates and Forecasts (2021–2032)

1.4.3 Global Semi-Solid Dose Production Estimates and Forecasts (2021–2032)

1.4.4 Global Semi-Solid Dose Market Average Price Estimates and Forecasts (2021–2032)

1.5 Assumptions and Limitations

2 Market Competition by Manufacturers

2.1 Global Semi-Solid Dose Production Market Share by Manufacturers (2021–2026)

2.2 Global Semi-Solid Dose Production Value Market Share by Manufacturers (2021–2026)

2.3 Global Key Players of Semi-Solid Dose, Industry Ranking, 2024 vs 2025

2.4 Global Semi-Solid Dose Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.5 Global Semi-Solid Dose Average Price by Manufacturers (2021–2026)

2.6 Global Key Manufacturers of Semi-Solid Dose, Manufacturing Footprints and Headquarters

2.7 Global Key Manufacturers of Semi-Solid Dose, Product Offerings and Applications

2.8 Global Key Manufacturers of Semi-Solid Dose, Date of Entry into the Industry

2.9 Semi-Solid Dose Market Competitive Situation and Trends

2.9.1 Semi-Solid Dose Market Concentration Rate

2.9.2 Top 5 and Top 10 Global Semi-Solid Dose Players Market Share by Revenue

2.10 Mergers & Acquisitions and Expansion

3 Semi-Solid Dose Production by Region

3.1 Global Semi-Solid Dose Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032

3.2 Global Semi-Solid Dose Production Value by Region (2021–2032)

3.2.1 Global Semi-Solid Dose Production Value by Region (2021–2026)

3.2.2 Global Forecasted Production Value of Semi-Solid Dose by Region (2027–2032)

3.3 Global Semi-Solid Dose Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032

3.4 Global Semi-Solid Dose Production Volume by Region (2021–2032)

3.4.1 Global Semi-Solid Dose Production by Region (2021–2026)

3.4.2 Global Forecasted Production of Semi-Solid Dose by Region (2027–2032)

3.5 Global Semi-Solid Dose Market Price Analysis by Region (2021–2026)

3.6 Global Semi-Solid Dose Production, Value, and Year-over-Year Growth

3.6.1 North America Semi-Solid Dose Production Value Estimates and Forecasts (2021–2032)

3.6.2 Europe Semi-Solid Dose Production Value Estimates and Forecasts (2021–2032)

3.6.3 China Semi-Solid Dose Production Value Estimates and Forecasts (2021–2032)

3.6.4 Japan Semi-Solid Dose Production Value Estimates and Forecasts (2021–2032)

4 Semi-Solid Dose Consumption by Region

4.1 Global Semi-Solid Dose Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032

4.2 Global Semi-Solid Dose Consumption by Region (2021–2032)

4.2.1 Global Semi-Solid Dose Consumption by Region (2021–2026)

4.2.2 Global Semi-Solid Dose Forecasted Consumption by Region (2027–2032)

4.3 North America

4.3.1 North America Semi-Solid Dose Consumption Growth Rate by Country: 2021 vs 2025 vs 2032

4.3.2 North America Semi-Solid Dose Consumption by Country (2021–2032)

4.3.3 U.S.

4.3.4 Canada

4.4 Europe

4.4.1 Europe Semi-Solid Dose Consumption Growth Rate by Country: 2021 vs 2025 vs 2032

4.4.2 Europe Semi-Solid Dose Consumption by Country (2021–2032)

4.4.3 Germany

4.4.4 France

4.4.5 U.K.

4.4.6 Italy

4.4.7 Russia

4.5 Asia Pacific

4.5.1 Asia Pacific Semi-Solid Dose Consumption Growth Rate by Region: 2021 vs 2025 vs 2032

4.5.2 Asia Pacific Semi-Solid Dose Consumption by Region (2021–2032)

4.5.3 China

4.5.4 Japan

4.5.5 South Korea

4.5.6 China Taiwan

4.5.7 Southeast Asia

4.5.8 India

4.6 Latin America, Middle East & Africa

4.6.1 Latin America, Middle East & Africa Semi-Solid Dose Consumption Growth Rate by Country: 2021 vs 2025 vs 2032

4.6.2 Latin America, Middle East & Africa Semi-Solid Dose Consumption by Country (2021–2032)

4.6.3 Mexico

4.6.4 Brazil

4.6.5 Turkey

4.6.6 GCC Countries

5 Segment by Type

5.1 Global Semi-Solid Dose Production by Type (2021–2032)

5.1.1 Global Semi-Solid Dose Production by Type (2021–2026)

5.1.2 Global Semi-Solid Dose Production by Type (2027–2032)

5.1.3 Global Semi-Solid Dose Production Market Share by Type (2021–2032)

5.2 Global Semi-Solid Dose Production Value by Type (2021–2032)

5.2.1 Global Semi-Solid Dose Production Value by Type (2021–2026)

5.2.2 Global Semi-Solid Dose Production Value by Type (2027–2032)

5.2.3 Global Semi-Solid Dose Production Value Market Share by Type (2021–2032)

5.3 Global Semi-Solid Dose Price by Type (2021–2032)

6 Segment by Application

6.1 Global Semi-Solid Dose Production by Application (2021–2032)

6.1.1 Global Semi-Solid Dose Production by Application (2021–2026)

6.1.2 Global Semi-Solid Dose Production by Application (2027–2032)

6.1.3 Global Semi-Solid Dose Production Market Share by Application (2021–2032)

6.2 Global Semi-Solid Dose Production Value by Application (2021–2032)

6.2.1 Global Semi-Solid Dose Production Value by Application (2021–2026)

6.2.2 Global Semi-Solid Dose Production Value by Application (2027–2032)

6.2.3 Global Semi-Solid Dose Production Value Market Share by Application (2021–2032)

6.3 Global Semi-Solid Dose Price by Application (2021–2032)

7 Key Companies Profiled

7.1 Johnson & Johnson

7.1.1 Johnson & Johnson Semi-Solid Dose Company Information

7.1.2 Johnson & Johnson Semi-Solid Dose Product Portfolio

7.1.3 Johnson & Johnson Semi-Solid Dose Production, Value, Price, and Gross Margin (2021–2026)

7.1.4 Johnson & Johnson Main Business and Markets Served

7.1.5 Johnson & Johnson Recent Developments/Updates

7.2 Merck & Co

7.2.1 Merck & Co Semi-Solid Dose Company Information

7.2.2 Merck & Co Semi-Solid Dose Product Portfolio

7.2.3 Merck & Co Semi-Solid Dose Production, Value, Price, and Gross Margin (2021–2026)

7.2.4 Merck & Co Main Business and Markets Served

7.2.5 Merck & Co Recent Developments/Updates

7.3 Bayer AG

7.3.1 Bayer AG Semi-Solid Dose Company Information

7.3.2 Bayer AG Semi-Solid Dose Product Portfolio

7.3.3 Bayer AG Semi-Solid Dose Production, Value, Price, and Gross Margin (2021–2026)

7.3.4 Bayer AG Main Business and Markets Served

7.3.5 Bayer AG Recent Developments/Updates

7.4 Hisamitsu Pharmaceutical

7.4.1 Hisamitsu Pharmaceutical Semi-Solid Dose Company Information

7.4.2 Hisamitsu Pharmaceutical Semi-Solid Dose Product Portfolio

7.4.3 Hisamitsu Pharmaceutical Semi-Solid Dose Production, Value, Price, and Gross Margin (2021–2026)

7.4.4 Hisamitsu Pharmaceutical Main Business and Markets Served

7.4.5 Hisamitsu Pharmaceutical Recent Developments/Updates

7.5 Glenmark Pharmaceuticals

7.5.1 Glenmark Pharmaceuticals Semi-Solid Dose Company Information

7.5.2 Glenmark Pharmaceuticals Semi-Solid Dose Product Portfolio

7.5.3 Glenmark Pharmaceuticals Semi-Solid Dose Production, Value, Price, and Gross Margin (2021–2026)

7.5.4 Glenmark Pharmaceuticals Main Business and Markets Served

7.5.5 Glenmark Pharmaceuticals Recent Developments/Updates

7.6 Cipla Ltd

7.6.1 Cipla Ltd Semi-Solid Dose Company Information

7.6.2 Cipla Ltd Semi-Solid Dose Product Portfolio

7.6.3 Cipla Ltd Semi-Solid Dose Production, Value, Price, and Gross Margin (2021–2026)

7.6.4 Cipla Ltd Main Business and Markets Served

7.6.5 Cipla Ltd Recent Developments/Updates

7.7 Nestle SA

7.7.1 Nestle SA Semi-Solid Dose Company Information

7.7.2 Nestle SA Semi-Solid Dose Product Portfolio

7.7.3 Nestle SA Semi-Solid Dose Production, Value, Price, and Gross Margin (2021–2026)

7.7.4 Nestle SA Main Business and Markets Served

7.7.5 Nestle SA Recent Developments/Updates

7.8 Novartis AG

7.8.1 Novartis AG Semi-Solid Dose Company Information

7.8.2 Novartis AG Semi-Solid Dose Product Portfolio

7.8.3 Novartis AG Semi-Solid Dose Production, Value, Price, and Gross Margin (2021–2026)

7.8.4 Novartis AG Main Business and Markets Served

7.8.5 Novartis AG Recent Developments/Updates

7.9 GlaxoSmithKline plc

7.9.1 GlaxoSmithKline plc Semi-Solid Dose Company Information

7.9.2 GlaxoSmithKline plc Semi-Solid Dose Product Portfolio

7.9.3 GlaxoSmithKline plc Semi-Solid Dose Production, Value, Price, and Gross Margin (2021–2026)

7.9.4 GlaxoSmithKline plc Main Business and Markets Served

7.9.5 GlaxoSmithKline plc Recent Developments/Updates

7.10 Bausch Health Companies

7.10.1 Bausch Health Companies Semi-Solid Dose Company Information

7.10.2 Bausch Health Companies Semi-Solid Dose Product Portfolio

7.10.3 Bausch Health Companies Semi-Solid Dose Production, Value, Price, and Gross Margin (2021–2026)

7.10.4 Bausch Health Companies Main Business and Markets Served

7.10.5 Bausch Health Companies Recent Developments/Updates

8 Industry Chain and Sales Channels Analysis

8.1 Semi-Solid Dose Industry Chain Analysis

8.2 Semi-Solid Dose Raw Material Supply Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.3 Semi-Solid Dose Production Modes and Processes

8.4 Semi-Solid Dose Sales and Marketing

8.4.1 Semi-Solid Dose Sales Channels

8.4.2 Semi-Solid Dose Distributors

8.5 Semi-Solid Dose Customer Analysis

9 Semi-Solid Dose Market Dynamics

9.1 Semi-Solid Dose Industry Trends

9.2 Semi-Solid Dose Market Drivers

9.3 Semi-Solid Dose Market Challenges

9.4 Semi-Solid Dose Market Restraints

9.5 Impact of U.S. Tariffs

10 Research Findings and Conclusion

11 Methodology and Data Source

11.1 Methodology/Research Approach

11.1.1 Research Programs/Design

11.1.2 Market Size Estimation

11.1.3 Market Breakdown and Data Triangulation

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Author List

11.4 Disclaimer

FEATURED COMPANIES

Johnson & Johnson

Merck

Bayer

Glenmark Pharmaceuticals

Cipla Ltd

Nestle SA

Novartis

GlaxoSmithKline PLC

Bausch Health Companies

Hisamitsu Pharmaceutical

Johnson & Johnson

List of Tables

Table 1. Global Semi-Solid Dose Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Semi-Solid Dose Market Value by Application (US$ Million), 2025 vs 2032

Table 3. Global Semi-Solid Dose Production Capacity (Tons) by Manufacturers in 2025

Table 4. Global Semi-Solid Dose Production by Manufacturers (Tons), 2021–2026

Table 5. Global Semi-Solid Dose Production Market Share by Manufacturers (2021–2026)

Table 6. Global Semi-Solid Dose Production Value by Manufacturers (US$ Million), 2021–2026

Table 7. Global Semi-Solid Dose Production Value Share by Manufacturers (2021–2026)

Table 8. Global Key Players of Semi-Solid Dose, Industry Ranking, 2024 vs 2025

Table 9. Classification of Companies by Tier (Tier 1, Tier 2, Tier 3), based on Semi-Solid Dose Production Value, 2025

Table 10. Global Market Semi-Solid Dose Average Price by Manufacturers (US$/Ton), 2021–2026

Table 11. Global Key Manufacturers of Semi-Solid Dose, Manufacturing Footprints and Headquarters

Table 12. Global Key Manufacturers of Semi-Solid Dose, Product Offerings and Applications

Table 13. Global Key Manufacturers of Semi-Solid Dose, Date of Entry into the Industry

Table 14. Global Semi-Solid Dose Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 15. Mergers & Acquisitions and Expansion Plans

Table 16. Global Semi-Solid Dose Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 17. Global Semi-Solid Dose Production Value (US$ Million) by Region (2021–2026)

Table 18. Global Semi-Solid Dose Production Value Market Share by Region (2021–2026)

Table 19. Global Semi-Solid Dose Production Value (US$ Million) Forecast by Region (2027–2032)

Table 20. Global Semi-Solid Dose Production Value Market Share Forecast by Region (2027–2032)

Table 21. Global Semi-Solid Dose Production Comparison by Region: 2021 vs 2025 vs 2032 (Tons)

Table 22. Global Semi-Solid Dose Production (Tons) by Region (2021–2026)

Table 23. Global Semi-Solid Dose Production Market Share by Region (2021–2026)

Table 24. Global Semi-Solid Dose Production (Tons) Forecast by Region (2027–2032)

Table 25. Global Semi-Solid Dose Production Market Share Forecast by Region (2027–2032)

Table 26. Global Semi-Solid Dose Market Average Price (US$/Ton) by Region (2021–2026)

Table 27. Global Semi-Solid Dose Market Average Price (US$/Ton) by Region (2027–2032)

Table 28. Global Semi-Solid Dose Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (Tons)

Table 29. Global Semi-Solid Dose Consumption by Region (Tons), 2021–2026

Table 30. Global Semi-Solid Dose Consumption Market Share by Region (2021–2026)

Table 31. Global Semi-Solid Dose Forecasted Consumption by Region (Tons), 2027–2032

Table 32. Global Semi-Solid Dose Forecasted Consumption Market Share by Region (2027–2032)

Table 33. North America Semi-Solid Dose Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (Tons)

Table 34. North America Semi-Solid Dose Consumption by Country (Tons), 2021–2026

Table 35. North America Semi-Solid Dose Consumption by Country (Tons), 2027–2032

Table 36. Europe Semi-Solid Dose Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (Tons)

Table 37. Europe Semi-Solid Dose Consumption by Country (Tons), 2021–2026

Table 38. Europe Semi-Solid Dose Consumption by Country (Tons), 2027–2032

Table 39. Asia Pacific Semi-Solid Dose Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (Tons)

Table 40. Asia Pacific Semi-Solid Dose Consumption by Region (Tons), 2021–2026

Table 41. Asia Pacific Semi-Solid Dose Consumption by Region (Tons), 2027–2032

Table 42. Latin America, Middle East & Africa Semi-Solid Dose Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (Tons)

Table 43. Latin America, Middle East & Africa Semi-Solid Dose Consumption by Country (Tons), 2021–2026

Table 44. Latin America, Middle East & Africa Semi-Solid Dose Consumption by Country (Tons), 2027–2032

Table 45. Global Semi-Solid Dose Production (Tons) by Type (2021–2026)

Table 46. Global Semi-Solid Dose Production (Tons) by Type (2027–2032)

Table 47. Global Semi-Solid Dose Production Market Share by Type (2021–2026)

Table 48. Global Semi-Solid Dose Production Market Share by Type (2027–2032)

Table 49. Global Semi-Solid Dose Production Value (US$ Million) by Type (2021–2026)

Table 50. Global Semi-Solid Dose Production Value (US$ Million) by Type (2027–2032)

Table 51. Global Semi-Solid Dose Production Value Market Share by Type (2021–2026)

Table 52. Global Semi-Solid Dose Production Value Market Share by Type (2027–2032)

Table 53. Global Semi-Solid Dose Price (US$/Ton) by Type (2021–2026)

Table 54. Global Semi-Solid Dose Price (US$/Ton) by Type (2027–2032)

Table 55. Global Semi-Solid Dose Production (Tons) by Application (2021–2026)

Table 56. Global Semi-Solid Dose Production (Tons) by Application (2027–2032)

Table 57. Global Semi-Solid Dose Production Market Share by Application (2021–2026)

Table 58. Global Semi-Solid Dose Production Market Share by Application (2027–2032)

Table 59. Global Semi-Solid Dose Production Value (US$ Million) by Application (2021–2026)

Table 60. Global Semi-Solid Dose Production Value (US$ Million) by Application (2027–2032)

Table 61. Global Semi-Solid Dose Production Value Market Share by Application (2021–2026)

Table 62. Global Semi-Solid Dose Production Value Market Share by Application (2027–2032)

Table 63. Global Semi-Solid Dose Price (US$/Ton) by Application (2021–2026)

Table 64. Global Semi-Solid Dose Price (US$/Ton) by Application (2027–2032)

Table 65. Johnson & Johnson Semi-Solid Dose Company Information

Table 66. Johnson & Johnson Semi-Solid Dose Specification and Application

Table 67. Johnson & Johnson Semi-Solid Dose Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)

Table 68. Johnson & Johnson Main Business and Markets Served

Table 69. Johnson & Johnson Recent Developments/Updates

Table 70. Merck & Co Semi-Solid Dose Company Information

Table 71. Merck & Co Semi-Solid Dose Specification and Application

Table 72. Merck & Co Semi-Solid Dose Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)

Table 73. Merck & Co Main Business and Markets Served

Table 74. Merck & Co Recent Developments/Updates

Table 75. Bayer AG Semi-Solid Dose Company Information

Table 76. Bayer AG Semi-Solid Dose Specification and Application

Table 77. Bayer AG Semi-Solid Dose Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)

Table 78. Bayer AG Main Business and Markets Served

Table 79. Bayer AG Recent Developments/Updates

Table 80. Hisamitsu Pharmaceutical Semi-Solid Dose Company Information

Table 81. Hisamitsu Pharmaceutical Semi-Solid Dose Specification and Application

Table 82. Hisamitsu Pharmaceutical Semi-Solid Dose Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)

Table 83. Hisamitsu Pharmaceutical Main Business and Markets Served

Table 84. Hisamitsu Pharmaceutical Recent Developments/Updates

Table 85. Glenmark Pharmaceuticals Semi-Solid Dose Company Information

Table 86. Glenmark Pharmaceuticals Semi-Solid Dose Specification and Application

Table 87. Glenmark Pharmaceuticals Semi-Solid Dose Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)

Table 88. Glenmark Pharmaceuticals Main Business and Markets Served

Table 89. Glenmark Pharmaceuticals Recent Developments/Updates

Table 90. Cipla Ltd Semi-Solid Dose Company Information

Table 91. Cipla Ltd Semi-Solid Dose Specification and Application

Table 92. Cipla Ltd Semi-Solid Dose Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)

Table 93. Cipla Ltd Main Business and Markets Served

Table 94. Cipla Ltd Recent Developments/Updates

Table 95. Nestle SA Semi-Solid Dose Company Information

Table 96. Nestle SA Semi-Solid Dose Specification and Application

Table 97. Nestle SA Semi-Solid Dose Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)

Table 98. Nestle SA Main Business and Markets Served

Table 99. Nestle SA Recent Developments/Updates

Table 100. Novartis AG Semi-Solid Dose Company Information

Table 101. Novartis AG Semi-Solid Dose Specification and Application

Table 102. Novartis AG Semi-Solid Dose Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)

Table 103. Novartis AG Main Business and Markets Served

Table 104. Novartis AG Recent Developments/Updates

Table 105. GlaxoSmithKline plc Semi-Solid Dose Company Information

Table 106. GlaxoSmithKline plc Semi-Solid Dose Specification and Application

Table 107. GlaxoSmithKline plc Semi-Solid Dose Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)

Table 108. GlaxoSmithKline plc Main Business and Markets Served

Table 109. GlaxoSmithKline plc Recent Developments/Updates

Table 110. Bausch Health Companies Semi-Solid Dose Company Information

Table 111. Bausch Health Companies Semi-Solid Dose Specification and Application

Table 112. Bausch Health Companies Semi-Solid Dose Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)

Table 113. Bausch Health Companies Main Business and Markets Served

Table 114. Bausch Health Companies Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. Semi-Solid Dose Distributors List

Table 118. Semi-Solid Dose Customers List

Table 119. Semi-Solid Dose Market Trends

Table 120. Semi-Solid Dose Market Drivers

Table 121. Semi-Solid Dose Market Challenges

Table 122. Semi-Solid Dose Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. Authors List of This Report

List of Figures

Figure 1. Product Picture of Semi-Solid Dose

Figure 2. Global Semi-Solid Dose Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Semi-Solid Dose Market Share by Type: 2025 vs 2032

Figure 4. Ointments Product Picture

Figure 5. Pastes Product Picture

Figure 6. Gels Product Picture

Figure 7. Global Semi-Solid Dose Market Value by Application (US$ Million), 2021–2032

Figure 8. Global Semi-Solid Dose Market Share by Application: 2025 vs 2032

Figure 9. Skin

Figure 10. Nasal Cavity

Figure 11. Vaginal Cavity

Figure 12. Rectal Cavity

Figure 13. Others

Figure 14. Global Semi-Solid Dose Production Value (US$ Million), 2021 vs 2025 vs 2032

Figure 15. Global Semi-Solid Dose Production Value (US$ Million), 2021–2032

Figure 16. Global Semi-Solid Dose Production Capacity (Tons), 2021–2032

Figure 17. Global Semi-Solid Dose Production (Tons), 2021–2032

Figure 18. Global Semi-Solid Dose Average Price (US$/Ton), 2021–2032

Figure 19. Semi-Solid Dose Report Years Considered

Figure 20. Semi-Solid Dose Production Share by Manufacturers in 2025

Figure 21. Global Semi-Solid Dose Production Value Share by Manufacturers (2025)

Figure 22. Semi-Solid Dose Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 23. Top 5 and Top 10 Global Players: Market Share by Semi-Solid Dose Revenue in 2025

Figure 24. Global Semi-Solid Dose Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)

Figure 25. Global Semi-Solid Dose Production Value Market Share by Region: 2021 vs 2025 vs 2032

Figure 26. Global Semi-Solid Dose Production Comparison by Region: 2021 vs 2025 vs 2032 (Tons)

Figure 27. Global Semi-Solid Dose Production Market Share by Region: 2021 vs 2025 vs 2032

Figure 28. North America Semi-Solid Dose Production Value (US$ Million) Growth Rate (2021–2032)

Figure 29. Europe Semi-Solid Dose Production Value (US$ Million) Growth Rate (2021–2032)

Figure 30. China Semi-Solid Dose Production Value (US$ Million) Growth Rate (2021–2032)

Figure 31. Japan Semi-Solid Dose Production Value (US$ Million) Growth Rate (2021–2032)

Figure 32. Global Semi-Solid Dose Consumption by Region: 2021 vs 2025 vs 2032 (Tons)

Figure 33. Global Semi-Solid Dose Consumption Market Share by Region: 2021 vs 2025 vs 2032

Figure 34. North America Semi-Solid Dose Consumption and Growth Rate (Tons), 2021–2032

Figure 35. North America Semi-Solid Dose Consumption Market Share by Country (2021–2032)

Figure 36. U.S. Semi-Solid Dose Consumption and Growth Rate (Tons), 2021–2032

Figure 37. Canada Semi-Solid Dose Consumption and Growth Rate (Tons), 2021–2032

Figure 38. Europe Semi-Solid Dose Consumption and Growth Rate (Tons), 2021–2032

Figure 39. Europe Semi-Solid Dose Consumption Market Share by Country (2021–2032)

Figure 40. Germany Semi-Solid Dose Consumption and Growth Rate (Tons), 2021–2032

Figure 41. France Semi-Solid Dose Consumption and Growth Rate (Tons), 2021–2032

Figure 42. U.K. Semi-Solid Dose Consumption and Growth Rate (Tons), 2021–2032

Figure 43. Italy Semi-Solid Dose Consumption and Growth Rate (Tons), 2021–2032

Figure 44. Russia Semi-Solid Dose Consumption and Growth Rate (Tons), 2021–2032

Figure 45. Asia Pacific Semi-Solid Dose Consumption and Growth Rate (Tons), 2021–2032

Figure 46. Asia Pacific Semi-Solid Dose Consumption Market Share by Region (2021–2032)

Figure 47. China Semi-Solid Dose Consumption and Growth Rate (Tons), 2021–2032

Figure 48. Japan Semi-Solid Dose Consumption and Growth Rate (Tons), 2021–2032

Figure 49. South Korea Semi-Solid Dose Consumption and Growth Rate (Tons), 2021–2032

Figure 50. China Taiwan Semi-Solid Dose Consumption and Growth Rate (Tons), 2021–2032

Figure 51. Southeast Asia Semi-Solid Dose Consumption and Growth Rate (Tons), 2021–2032

Figure 52. India Semi-Solid Dose Consumption and Growth Rate (Tons), 2021–2032

Figure 53. Latin America, Middle East & Africa Semi-Solid Dose Consumption and Growth Rate (Tons), 2021–2032

Figure 54. Latin America, Middle East & Africa Semi-Solid Dose Consumption Market Share by Country (2021–2032)

Figure 55. Mexico Semi-Solid Dose Consumption and Growth Rate (Tons), 2021–2032

Figure 56. Brazil Semi-Solid Dose Consumption and Growth Rate (Tons), 2021–2032

Figure 57. Turkey Semi-Solid Dose Consumption and Growth Rate (Tons), 2021–2032

Figure 58. GCC Countries Semi-Solid Dose Consumption and Growth Rate (Tons), 2021–2032

Figure 59. Global Production Market Share of Semi-Solid Dose by Type (2021–2032)

Figure 60. Global Production Value Market Share of Semi-Solid Dose by Type (2021–2032)

Figure 61. Global Semi-Solid Dose Price (US$/Ton) by Type (2021–2032)

Figure 62. Global Production Market Share of Semi-Solid Dose by Application (2021–2032)

Figure 63. Global Production Value Market Share of Semi-Solid Dose by Application (2021–2032)

Figure 64. Global Semi-Solid Dose Price (US$/Ton) by Application (2021–2032)

Figure 65. Semi-Solid Dose Value Chain

Figure 66. Channels of Distribution (Direct Vs Distribution)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Oral Solid Dose Market Research Report 2024

Solid Dosage Form Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Solid Preparation Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global External Semi Solid Preparation Market Research Report 2024

Global Liquid Formulations Drug Delivery Market Research Report 2025

Global Pharmaceutical Excipients for Oral Formulations Market Research Report 2024

Global Diuron Market Insights Forecast to 2030

Non prescription Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Semi solid Flow Battery Market Research Report 2025

Global Oral Solid Dosage Pharmaceutical Formulation Market Research Report 2024

Global Semi solid Battery for Automobiles Market Research Report 2025

Global Pharmaceutical Neutral Pellet Market Research Report 2024

Global Patient Adherence and Compliance Market Research Report 2024

Global Pharmaceutical Pellet Core Market Research Report 2024

Global Pharmaceutical Spheres Market Research Report 2024

Retail Drug Market

Global OTC Test Device Market Research Report 2024

Global Electric Vehicle Semi solid Battery Market Research Report 2024

Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions